Scientists have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade ...

Early in the beginning of the COVID-19 pandemic, scientists predicted the coronavirus would mutate slowly. They were wrong. Hundreds of thousands of viral mutations and multiple seasonal waves later, ...

New research from the University of Kansas shows a "risk gene" linked to higher odds of developing autoimmune diseases such ...

Researchers mapped more than 100 mutations that allow diverse HIV-1 strains to evade broadly neutralizing antibodies.

Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego ...

Tevogen Bio files patent for T cell vaccine targeting entire viral genome, enhancing immune response against mutations and viral infections. Tevogen Bio, a clinical-stage immunotherapy biotech company ...

This month’s story comes from the Bloom lab using their signature deep mutational scanning technique to identify mutations in the surface protein of Lassa virus -called glycoprotein- that escape ...

New York, NY, October 23, 2024 — Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an innovative antibody platform aimed at ...